CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

VALIANT LABORATORIES LTD.

NSE : VALIANTLABBSE : 543998ISIN CODE : INE0JWS01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE93.91-2.51 (-2.6 %)
PREV CLOSE () 96.42
OPEN PRICE () 97.81
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1920
TODAY'S LOW / HIGH ()93.31 98.05
52 WK LOW / HIGH ()75.86 168.05
NSE93.58-3.3 (-3.41 %)
PREV CLOSE() 96.88
OPEN PRICE () 97.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 93.58 (41)
VOLUME 81272
TODAY'S LOW / HIGH() 92.25 97.95
52 WK LOW / HIGH ()75.2 168
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2021

Management Info :

Velji Gogri - Chairman Santosh S Vora - Managing Director

Registered Office :

Address : 104, Udyog Kshetra,Mulund Goregaon Link Road,Mulund (West),
Mumbai,
Maharashtra-400080

Phone : 022-49712001 / 49717220 / 49717221

Website : www.valiantlabs.in

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
19Feb Valiant Laboratories informs about cre
Valiant Laboratories has informed that CRISIL Ratings have issued the fo..
20Dec Valiant Laboratories informs about vot
In continuation to earlier intimation dated November 19, 2024, informing..
23Aug Valiant Laboratories informs about cre
Valiant Laboratories has informed that CRISIL Ratings have issued the cr..
14Aug Valiant Laboratories informs about new
Valiant Laboratories has informed that it enclosed copies of the newspap..
21Jun Valiant Laboratories informs about dis
With reference to letter dated October 23, 2023, Valiant Laboratories ha..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit163.39999999999979
Gross Profit 7.18999999999998 -7.53000000000021
Operating Profit 12.912.7299999999998
Net Sales 352.281820.52
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
SMS Lifesciences (BSE)
 1272.45 (10.55%)
M.Cap ( in Cr)
387.28
Mankind Pharma (BSE)
 2522.45 (3.89%)
M.Cap ( in Cr)
104070.87
Neuland Laboratories (BSE)
 12742.10 (0.69%)
M.Cap ( in Cr)
16251.62
Glaxosmithkline Phar (BSE)
 2928.60 (1.81%)
M.Cap ( in Cr)
49612.25
Emcure Pharma (BSE)
 1003.05 (5.16%)
M.Cap ( in Cr)
19177.61
Shareholding Pattern
PROMOTERS 74.94%
NON-INSTITUTION 25.06%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77044.29309.40 (0.40%)
NIFTY23437.20108.65 (0.47%)
Dow Jones 40368.96-155.83 (-0.38%)
Nasdaq 16823.17-8.31 (-0.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI